Phase II Study of Single Agent Lenvatinib
Clinical trial NCT03168074 · UNKNOWN
Trial details
- NCT number
- NCT03168074
- Sponsor
- National University Hospital, Singapore
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-28
- Primary completion
- 2021-03-28
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.